RN

Robert J. Nelson

3M: 29 patents #374 of 11,543Top 4%
SA Siemens Aktiengesellschaft: 17 patents #444 of 22,248Top 2%
SP Siemens Westinghouse Power: 9 patents #12 of 394Top 4%
SE Siemens Energy: 6 patents #110 of 1,016Top 15%
Abbott: 5 patents #1,306 of 5,431Top 25%
WE Westinghouse Electric: 4 patents #781 of 5,139Top 20%
AB Aclara Biosciences: 4 patents #13 of 53Top 25%
SE Siemens Gamesa Renewable Energy: 3 patents #89 of 493Top 20%
Northwestern University: 3 patents #516 of 3,846Top 15%
TL The Boc Group Limited: 2 patents #160 of 612Top 30%
SG Siemens Power Generation: 1 patents #74 of 257Top 30%
AD Arizona Technology Development: 1 patents #3 of 27Top 15%
SB Soane Biosciences: 1 patents #5 of 8Top 65%
MP Medicon Pharmaceuticals: 1 patents #38 of 73Top 55%
KE Kelsey-Hayes-Company: 1 patents #155 of 387Top 45%
IT Integrated Device Technology: 1 patents #441 of 758Top 60%
📍 Orlando, FL: #8 of 4,387 inventorsTop 1%
🗺 Florida: #193 of 67,251 inventorsTop 1%
Overall (All Time): #17,617 of 4,157,543Top 1%
91
Patents All Time

Issued Patents All Time

Showing 26–50 of 91 patents

Patent #TitleCo-InventorsDate
7928117 Method of inducing cytokine biosynthesis Alexis S. Statham 2011-04-19
7928116 Method of treating actinic keratosis Alexis S. Statham 2011-04-19
7923463 Methods for stabilizing imiquimod for two months, four months, and six months Alexis S. Statham 2011-04-12
7919501 Method of controlling formation of imiquimod impurities Alexis S. Statham 2011-04-05
7915279 Method of treating mollescum contagiosum Alexis S. Statham 2011-03-29
7915278 Method of treating basal cell carcinoma Alexis S. Statham 2011-03-29
7915277 Method of treating genital or peri-anal warts Alexis S. Statham 2011-03-29
7906524 Pharmaceutical cream having similar or less levels of imiquimod impurity formation as cream with BHA (comparator) Alexis S. Statham 2011-03-15
7906525 Reduction of imiquimod impurities at four months using refined oleic acid Alexis S. Statham 2011-03-15
7906526 Method of treating a dermal and/or mucosal associated condition Alexis S. Statham 2011-03-15
7906527 Reduction of imiquimod impurities using refined oleic acid Alexis S. Statham 2011-03-15
7906543 Method of reducing imiquimod impurity formation Alexis S. Statham 2011-03-15
7902246 Methods for controlling formation of imiquimod impurities for two months, four months, and six months Alexis S. Statham 2011-03-08
7902245 Methods for reducing imiquimod impurities for two months, four months, and six months Alexis S. Statham 2011-03-08
7902244 Method of preparing a pharmaceutical cream and minimizing imiquimod impurity formation (at least four months storage) Alexis S. Statham 2011-03-08
7902243 Methods for improving imiquimod availability at two months, four months and six months between refined and compendial Alexis S. Statham 2011-03-08
7902242 Method of stabilizing imiquimod Alexis S. Statham 2011-03-08
7902216 Pharmaceutical creams with refined oleic acid Alexis S. Statham 2011-03-08
7902215 Pharmaceutical creams with reduced imiquimod impurities Alexis S. Statham 2011-03-08
7902214 Method of treating a mucosal and/or dermal associated condition Alexis S. Statham 2011-03-08
7902213 Pharmaceutical cream with reduced imiquimod impurities at four months using refined oleic acid Alexis S. Statham 2011-03-08
7902212 Reduction of imiquimod impurities at six months using refined oleic acid Alexis S. Statham 2011-03-08
7902211 Method of inducing interferon biosynthesis Alexis S. Statham 2011-03-08
7902210 Reduction of IMIQUIMOD impurities at two months using refined oleic acid Alexis S. Statham 2011-03-08
7902209 Method of preparing a pharmaceutical cream and minimizing imiquimod impurity formation Alexis S. Statham 2011-03-08